【序号】：1
【作者】：Kim TH, Jiang HH, Lim SM, Youn YS, Choi KY, Lee S, Chen X, Byun Y, Lee KC.
【题名】：Site-specific PEGylated Exendin-4 modified with a high molecular weight trimeric PEG reduces steric hindrance and increases type 2 antidiabetic therapeutic effects.
【期刊】：Bioconjug Chem.
【年、卷、期、起止页码】： 2012 Nov 21;23(11):2214-20. doi: 10.1021/bc300265n. Epub 2012 Nov 9.
【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/23116483

【序号】：2
【作者】：Yoshimoto N, Yamamoto S.
【题名】：PEGylated protein separations: challenges and opportunities.
【期刊】：Biotechnol J.
【年、卷、期、起止页码】：2012 May;7(5):592-3. doi: 10.1002/biot.201200143.
【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/22532415

【序号】：3
【作者】：Qian X, Dong H, Tian H, Tong Y, Guo L, Hu X, Gao X, Yao W.
【题名】：Characterization of a site-specific PEGylated analog of exendin-4 and determination of the PEGylation site.
【期刊】：Int J Pharm
【年、卷、期、起止页码】：2013 Sep 15;454(1):553-8. doi: 10.1016/j.ijpharm.2013.06.059. Epub 2013 Jul 1.
【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/23827193

【序号】：4
【作者】：Kunstelj M, Fidler K, Skrajnar S, Kenig M, Smilovi? V, Kusterle M, Caserman S, Zore I, Porekar VG, Jev?evar S.
【题名】：Cysteine-specific PEGylation of rhG-CSF via selenylsulfide bond.
【期刊】：Bioconjug Chem.
【年、卷、期、起止页码】：2013 Jun 19;24(6):889-96. doi: 10.1021/bc3005232. Epub 2013 May 10.
【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/23600957

【序号】：5
【作者】：Cong Y, Pawlisz E, Bryant P, Balan S, Laurine E, Tommasi R, Singh R, Dubey S, Peciak K, Bird M, Sivasankar A, Swierkosz J, Muroni M, Heidelberger S, Farys M, Khayrzad F, Edwards J, Badescu G, Hodgson I, Heise C, Somavarapu S, Liddell J, Powell K, Zloh M, Choi JW, Godwin A, Brocchini S.
【题名】：Site-specific PEGylation at histidine tags.
【期刊】：Bioconjug Chem
【年、卷、期、起止页码】：2012 Feb 15;23(2):248-63. doi: 10.1021/bc200530x. Epub 2012 Feb 6.
【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/22243664